Author:
Liu Qian,Sun Jessica D.,Wang Jingli,Ahluwalia Dharmendra,Baker Amanda F.,Cranmer Lee D.,Ferraro Damien,Wang Yan,Duan Jian-Xin,Ammons W. Steve,Curd John G.,Matteucci Mark D.,Hart Charles P.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference45 articles.
1. Batchelder RM, Wilson WR, Hay MP, Denny WA (1996) Oxygen dependence of the cytotoxicity of the enediyne anti-tumour antibiotic esperamicin A1. Br J Cancer Suppl 27:S52–S56
2. Bhattacharya A, Toth K, Durrani FA, Cao S, Slocum HK, Chintala S, Rustum YM (2008) Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts. Neoplasia 10:857–865
3. Borad M, Infante JR, Mita AC, Chiorean EG, Mendelson DS, Vlahovic G, Wilding G, Langmuir VK, Kroll S (2009) Multi-arm Phase IB study of TH-302 in combination with gemcitabine, docetaxel or pemetrexed. Eur J Cancer Suppl 7:128
4. Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4:437–447
5. Dorie MJ, Brown JM (1993) Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin. Cancer Res 53:4633–4636
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献